We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Moves to Lessen COVID-19’s Impact on Supply Chain
FDA Moves to Lessen COVID-19’s Impact on Supply Chain
FDA Commissioner Stephen Hahn said the agency is taking a “forward-leaning approach” to identify supply chain shortages caused by the coronavirus outbreak and isn’t waiting around for drugmakers to report them.